These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7684450)

  • 1. Bis(heteroaryl)piperazine (BHAP) reverse transcriptase inhibitors: structure-activity relationships of novel substituted indole analogues and the identification of 1-[(5-methanesulfonamido-1H-indol-2-yl)-carbonyl]-4-[3- [(1-methylethyl)amino]-pyridinyl]piperazine monomethanesulfonate (U-90152S), a second-generation clinical candidate.
    Romero DL; Morge RA; Genin MJ; Biles C; Busso M; Resnick L; Althaus IW; Reusser F; Thomas RC; Tarpley WG
    J Med Chem; 1993 May; 36(10):1505-8. PubMed ID: 7684450
    [No Abstract]   [Full Text] [Related]  

  • 2. Unique features in the structure of the complex between HIV-1 reverse transcriptase and the bis(heteroaryl)piperazine (BHAP) U-90152 explain resistance mutations for this nonnucleoside inhibitor.
    Esnouf RM; Ren J; Hopkins AL; Ross CK; Jones EY; Stammers DK; Stuart DI
    Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3984-9. PubMed ID: 9108091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery, synthesis, and bioactivity of bis(heteroaryl)piperazines. 1. A novel class of non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Romero DL; Morge RA; Biles C; Berrios-Pena N; May PD; Palmer JR; Johnson PD; Smith HW; Busso M; Tan CK
    J Med Chem; 1994 Apr; 37(7):999-1014. PubMed ID: 7512142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. U-90152, a potent inhibitor of human immunodeficiency virus type 1 replication.
    Dueweke TJ; Poppe SM; Romero DL; Swaney SM; So AG; Downey KM; Althaus IW; Reusser F; Busso M; Resnick L
    Antimicrob Agents Chemother; 1993 May; 37(5):1127-31. PubMed ID: 7685995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and bioactivity of novel bis(heteroaryl)piperazine (BHAP) reverse transcriptase inhibitors: structure-activity relationships and increased metabolic stability of novel substituted pyridine analogs.
    Genin MJ; Poel TJ; Yagi Y; Biles C; Althaus I; Keiser BJ; Kopta LA; Friis JM; Reusser F; Adams WJ; Olmsted RA; Voorman RL; Thomas RC; Romero DL
    J Med Chem; 1996 Dec; 39(26):5267-75. PubMed ID: 8978855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous mutations at Tyr-181 and Tyr-188 in HIV-1 reverse transcriptase prevents inhibition of RNA-dependent DNA polymerase activity by the bisheteroarylpiperazine (BHAP) U-90152s.
    Fan N; Rank KB; Evans DB; Thomas RC; Tarpley WG; Sharma SK
    FEBS Lett; 1995 Aug; 370(1-2):59-62. PubMed ID: 7544302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutation in reverse transcriptase of bis(heteroaryl)piperazine-resistant human immunodeficiency virus type 1 that confers increased sensitivity to other nonnucleoside inhibitors.
    Dueweke TJ; Pushkarskaya T; Poppe SM; Swaney SM; Zhao JQ; Chen IS; Stevenson M; Tarpley WG
    Proc Natl Acad Sci U S A; 1993 May; 90(10):4713-7. PubMed ID: 7685109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting delavirdine/atevirdine resistant HIV-1: identification of (alkylamino)piperidine-containing bis(heteroaryl)piperazines as broad spectrum HIV-1 reverse transcriptase inhibitors.
    Romero DL; Olmsted RA; Poel TJ; Morge RA; Biles C; Keiser BJ; Kopta LA; Friis JM; Hosley JD; Stefanski KJ; Wishka DG; Evans DB; Morris J; Stehle RG; Sharma SK; Yagi Y; Voorman RL; Adams WJ; Tarpley WG; Thomas RC
    J Med Chem; 1996 Sep; 39(19):3769-89. PubMed ID: 8809165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly favorable antiviral activity and resistance profile of the novel thiocarboxanilide pentenyloxy ether derivatives UC-781 and UC-82 as inhibitors of human immunodeficiency virus type 1 replication.
    Balzarini J; Pelemans H; Aquaro S; Perno CF; Witvrouw M; Schols D; De Clercq E; Karlsson A
    Mol Pharmacol; 1996 Aug; 50(2):394-401. PubMed ID: 8700148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of the breakthrough of human immunodeficiency virus type 1 (HIV-1) in cell culture by thiocarboxanilide derivatives when used individually or in combination with other HIV-1-specific inhibitors (i.e., TSAO derivatives).
    Balzarini J; Pérez-Pérez MJ; Vélazquez S; San-Félix A; Camarasa MJ; De Clercq E; Karlsson A
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5470-4. PubMed ID: 7539917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of resistance to U-90152S and sensitization to L-697,661 by a proline to leucine change at residue 236 of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase.
    Fan N; Evans DB; Rank KB; Thomas RC; Tarpley WG; Sharma SK
    FEBS Lett; 1995 Feb; 359(2-3):233-8. PubMed ID: 7532595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro inhibition of human immunodeficiency virus type 1 by a combination of delavirdine (U-90152) with protease inhibitor U-75875 or interferon-alpha.
    Pagano PJ; Chong KT
    J Infect Dis; 1995 Jan; 171(1):61-7. PubMed ID: 7528253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-human immunodeficiency virus type 1 activities of novel non-nucleoside reverse transcriptase inhibitors.
    Nottet HS; Oteman MH; Visser MR; Verhoef J
    J Antimicrob Chemother; 1994 Feb; 33(2):366-8. PubMed ID: 7514164
    [No Abstract]   [Full Text] [Related]  

  • 14. Indoline and piperazine containing derivatives as a novel class of mixed D(2)/D(4) receptor antagonists. Part 1: identification and structure-activity relationships.
    Zhao H; Thurkauf A; He X; Hodgetts K; Zhang X; Rachwal S; Kover RX; Hutchison A; Peterson J; Kieltyka A; Brodbeck R; Primus R; Wasley JW
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3105-9. PubMed ID: 12372512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-human immunodeficiency virus type 1 activities of U-90152 and U-75875 in human brain cell cultures.
    Peterson PK; Gekker G; Hu S; Chao CC
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2465-8. PubMed ID: 7530933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective non-nucleoside HIV-1 reverse transcriptase inhibitors. New 2,3-dihydrothiazolo[2,3-a]isoindol-5(9bH)-ones and related compounds with anti-HIV-1 activity.
    Mertens A; Zilch H; König B; Schäfer W; Poll T; Kampe W; Seidel H; Leser U; Leinert H
    J Med Chem; 1993 Aug; 36(17):2526-35. PubMed ID: 7689109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant (E138K)RT HIV-1 mutants or select for highly resistant (Y181C-->C181I)RT HIV-1 mutants.
    Balzarini J; Karlsson A; Sardana VV; Emini EA; Camarasa MJ; De Clercq E
    Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6599-603. PubMed ID: 7517553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity relationships of indole and benzimidazole piperazines as histamine H(4) receptor antagonists.
    Terzioglu N; van Rijn RM; Bakker RA; De Esch IJ; Leurs R
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5251-6. PubMed ID: 15454206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationships of the (alkylamino)piperidine-containing BHAP class of non-nucleoside reverse transcriptase inhibitors: effect of 3-alkylpyridine ring substitution.
    Genin MJ; Poel TJ; May PD; Kopta LA; Yagi Y; Olmsted RA; Friis JM; Voorman RL; Adams WJ; Thomas RC; Romero DL
    J Med Chem; 1999 Oct; 42(20):4140-9. PubMed ID: 10514284
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.